ArticleScientific reports2025
Exploring the relationship between fat mass index and metabolic syndrome among cancer patients in the U.S: An NHANES analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Relationship between dietary diversity and periodontitis: analysis of NHANES 2003-2014.Acta odontologica Scandinavica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data regarding the connection between Fat Mass Index (FMI) and Metabolic Syndrome (MetS) in cancer survivors remain limited. This study aimed to assess the association between FMI and the likelihood of MetS among cancer survivors by conducting a population-based cross-sectional study. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) to examine a sample of 799 adult cancer survivors, aged over 20 years old, spanning the years 1999-2006 and 2011-2018. MetS was defined according to the criteria established by the Adult Treatment Panel III of the National Cholesterol Education Program (NCEP). To explore the association between fat mass index FMI and the prevalence of MetS among cancer survivors, multivariate logistic regression analyses were conducted. Additionally, restricted cubic splines were used to assess both linear and nonlinear relationships between FMI and MetS. After adjusting for potential confounders, the logistic regression analysis of multistage weighted complex sampling data demonstrated that a higher FMI significantly increased the odds of developing MetS (odds ratio [OR] = 1.33, 95% confidence interval [CI]: 1.09-1.61, p = 0.01). This association remained robust when FMI was categorized into tertiles. Specifically, the adjusted ORs for MetS in the second and third tertiles were 4.80 (95% CI: 1.95-11.79) and 8.95 (95% CI: 2.51-31.94), respectively (p for trend = 0.001). Furthermore, our analysis indicated a significant nonlinear relationship between FMI and the likelihood of MetS (p < 0.0001). In this research, we discovered that an elevated FMI is significantly associated with a higher prevalence of MetS among cancer survivors in the U.S. adult population. These findings underscore the importance of managing body fat to prevent MetS in this group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.